Inhibition of the TRAIL Death Receptor by CMV Reveals Its Importance in NK Cell-Mediated Antiviral Defense
Author(s) -
Shilpi Verma,
Andrea Loewendorf,
Qiao Wang,
Bryan McDonald,
Alec Redwood,
Chris A. Benedict
Publication year - 2014
Publication title -
plos pathogens
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.719
H-Index - 206
eISSN - 1553-7374
pISSN - 1553-7366
DOI - 10.1371/journal.ppat.1004268
Subject(s) - biology , apoptosis , open reading frame , tumor necrosis factor alpha , innate immune system , receptor , immune system , viral replication , programmed cell death , microbiology and biotechnology , immunology , virology , gene , virus , genetics , peptide sequence
TNF-related apoptosis inducing ligand (TRAIL) death receptors (DR) regulate apoptosis and inflammation, but their role in antiviral defense is poorly understood. Cytomegaloviruses (CMV) encode many immune-modulatory genes that shape host immunity, and they utilize multiple strategies to target the TNF-family cytokines. Here we show that the m166 open reading frame (orf) of mouse CMV (MCMV) is strictly required to inhibit expression of TRAIL-DR in infected cells. An MCMV mutant lacking m166 expression (m166 stop ) is severely compromised for replication in vivo , most notably in the liver, and depleting natural killer (NK) cells, or infecting TRAIL-DR −/− mice, restored MCMV-m166 stop replication completely. These results highlight the critical importance for CMV to have evolved a strategy to inhibit TRAIL-DR signaling to thwart NK-mediated defenses.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom